The global icoxtrin market is expected to reach USD 1.5 billion by 2030.
North America accounted for the largest share of the global icoxtrin market in 2017 owing to its large population base, high prevalence of chronic kidney disease, and increasing number of patients undergoing APD or APD treatments. Europe followed North America with a share of 27% in 2017 owing to its large population base, high prevalence of chronic kidney disease, and increasing number of patients undergoing APD or APD treatments. Asia Pacific was third with a share of 23% in 2017 due to its large population base as well as an increase in awareness about renal diseases among people living there which has led them towards adopting preventive measures such as regular checkups at hospitals or clinics for early detection and treatment before it becomes too late.
Some Of The Growth Factors Of This Market:
- Icodextrin is a white, odorless powder that is soluble in water and alcohol.
- It is used as a food additive to improve the texture of low-fat foods such as ice cream, yogurt, and cheese.
- It can also be used in pharmaceuticals to control blood sugar levels in people with diabetes mellitus type 2 or gestational diabetes mellitus (GDM).
- Icodextrin has been shown to reduce postprandial glycemic excursions by slowing gastric emptying and increasing the viscosity of chyme entering the small intestine.
- The global market for icodextrin was valued at $1 billion in 2016.
Industry Growth Insights published a new data on “Icodextrin (CAS 337376-15-5) Market”. The research report is titled “Icodextrin (CAS 337376-15-5) Market research by Types (7.5? Icodextrin, 4? Icodextrin), By Applications (Ambulatory Peritoneal Dialysis (CAPD), Automatic Peritoneal Dialysis (APD), Others), By Players/Companies Baxter, FZBIOTECH”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Icodextrin (CAS 337376-15-5) Market Research Report
By Type
7.5? Icodextrin, 4? Icodextrin
By Application
Ambulatory Peritoneal Dialysis (CAPD), Automatic Peritoneal Dialysis (APD), Others
By Companies
Baxter, FZBIOTECH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Icodextrin (CAS 337376-15-5) Market Report Segments:
The global Icodextrin (CAS 337376-15-5) market is segmented on the basis of:
Types
7.5? Icodextrin, 4? Icodextrin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ambulatory Peritoneal Dialysis (CAPD), Automatic Peritoneal Dialysis (APD), Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- FZBIOTECH
 Market Overview.svg)
Highlights of The Icodextrin (CAS 337376-15-5) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 7.5? Icodextrin
- 4? Icodextrin
- By Application:
- Ambulatory Peritoneal Dialysis (CAPD)
- Automatic Peritoneal Dialysis (APD)
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Icodextrin (CAS 337376-15-5) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Icodextrin is a white to off-white powder with a sweet, slightly fruity odor. It is used as an excipient in pharmaceuticals and food products.
Some of the major companies in the icodextrin (cas 337376-15-5) market are Baxter, FZBIOTECH.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Icodextrin (CAS 337376-15-5) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Icodextrin (CAS 337376-15-5) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Icodextrin (CAS 337376-15-5) Market - Supply Chain
4.5. Global Icodextrin (CAS 337376-15-5) Market Forecast
4.5.1. Icodextrin (CAS 337376-15-5) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Icodextrin (CAS 337376-15-5) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Icodextrin (CAS 337376-15-5) Market Absolute $ Opportunity
5. Global Icodextrin (CAS 337376-15-5) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Type
5.3.1. 7.5? Icodextrin
5.3.2. 4? Icodextrin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Icodextrin (CAS 337376-15-5) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Application
6.3.1. Ambulatory Peritoneal Dialysis (CAPD)
6.3.2. Automatic Peritoneal Dialysis (APD)
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Icodextrin (CAS 337376-15-5) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Icodextrin (CAS 337376-15-5) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Icodextrin (CAS 337376-15-5) Demand Share Forecast, 2019-2026
9. North America Icodextrin (CAS 337376-15-5) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Application
9.4.1. Ambulatory Peritoneal Dialysis (CAPD)
9.4.2. Automatic Peritoneal Dialysis (APD)
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Type
9.7.1. 7.5? Icodextrin
9.7.2. 4? Icodextrin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Icodextrin (CAS 337376-15-5) Demand Share Forecast, 2019-2026
10. Latin America Icodextrin (CAS 337376-15-5) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Application
10.4.1. Ambulatory Peritoneal Dialysis (CAPD)
10.4.2. Automatic Peritoneal Dialysis (APD)
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Type
10.7.1. 7.5? Icodextrin
10.7.2. 4? Icodextrin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Icodextrin (CAS 337376-15-5) Demand Share Forecast, 2019-2026
11. Europe Icodextrin (CAS 337376-15-5) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Application
11.4.1. Ambulatory Peritoneal Dialysis (CAPD)
11.4.2. Automatic Peritoneal Dialysis (APD)
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Type
11.7.1. 7.5? Icodextrin
11.7.2. 4? Icodextrin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Icodextrin (CAS 337376-15-5) Demand Share, 2019-2026
12. Asia Pacific Icodextrin (CAS 337376-15-5) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Application
12.4.1. Ambulatory Peritoneal Dialysis (CAPD)
12.4.2. Automatic Peritoneal Dialysis (APD)
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Type
12.7.1. 7.5? Icodextrin
12.7.2. 4? Icodextrin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Icodextrin (CAS 337376-15-5) Demand Share, 2019-2026
13. Middle East & Africa Icodextrin (CAS 337376-15-5) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Application
13.4.1. Ambulatory Peritoneal Dialysis (CAPD)
13.4.2. Automatic Peritoneal Dialysis (APD)
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Icodextrin (CAS 337376-15-5) Market Size and Volume Forecast by Type
13.7.1. 7.5? Icodextrin
13.7.2. 4? Icodextrin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Icodextrin (CAS 337376-15-5) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Icodextrin (CAS 337376-15-5) Market: Market Share Analysis
14.2. Icodextrin (CAS 337376-15-5) Distributors and Customers
14.3. Icodextrin (CAS 337376-15-5) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Baxter
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. FZBIOTECH
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
